Stakeholders concerned with FDA’s definition of labeling in PDURS guidance
Regulatory NewsJeff Craven
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesPharmaceuticalsUnited StatesRegulatory NewsJeff CravenAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesPharmaceuticalsUnited States